NBIO withdrawn to acquire Monash IVF
Filed with ASX · · 1 page · English
Further to the ASX release dated 24 November 2025, Monash IVF Group Limited (ASX : MVF, the “Company” or “Monash IVF”) received correspondence today from the consortium comprising Genesis Capital Investment Management Pty Ltd ("Genesis Capital" or "Genesis") and WHSP Holdings Pty Limited ("Soul Patts") (together, the "Consortium") withdrawing the Consortium’s non-binding indicative proposal to acq
Story so far
Earlier from Monash IVF
- Monash IVF rejects NBIO proposal to acquire MVF
- 2025 AGM - Investor Presentation
- 2025 AGM - Chair Address
- Appointment of Chief Executive Officer and Managing Director
- S&P DJI Announces September 2025 Quarterly Rebalance
Later from Monash IVF
- 1H26 Appendix 4D and Financial Report
- MVF delivers 1H26 Underlying NPAT of $10.4m
- 1H26 Results Presentation
- Revised NBIO to acquire MVF
- Monash IVF rejects revised non-binding indicative proposal
Follow Monash IVF into a list and get an email when it puts out news.
Follow Monash IVF